Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study

被引：0
|
作者：
Stephen K. Tyring
Phoebe Rich
Yayoi Tada
Stefan Beeck
Izabella Messina
Jie Liu
Xiaohong Huang
Stephen Shumack
机构：
[1] University of Texas Health Science Center,Department of Dermatology, McGovern Medical School
[2] Oregon Health and Science University,undefined
[3] Teikyo University School of Medicine,undefined
[4] AbbVie Inc.,undefined
[5] St George Dermatology and Skin Cancer Centre,undefined
来源：
Dermatology and Therapy | 2023年 / 13卷
关键词：
Atopic dermatitis; Interleukin-23; Risankizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：595 / 608
页数：13
相关论文
共 50 条
  • [1] Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Tyring, Stephen K. K.
    Rich, Phoebe
    Tada, Yayoi
    Beeck, Stefan
    Messina, Izabella
    Liu, Jie
    Huang, Xiaohong
    Shumack, Stephen
    DERMATOLOGY AND THERAPY, 2023, 13 (02) : 595 - 608
  • [2] Killed Mycobacterium vaccae suspension in children with moderate-to-severe atopic dermatitis:: a randomized, double-blind, placebo-controlled trial
    Berth-Jones, J.
    Arkwright, P. D.
    Marasovic, D.
    Savani, N.
    Aldridge, C. R.
    Leech, S. N.
    Morgan, C.
    Clark, S. M.
    Ogilvie, S.
    Chopra, S.
    Harper, J. I.
    Smith, C. H.
    Rook, G. A. W.
    Friedmann, P. S.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2006, 36 (09) : 1115 - 1121
  • [3] Rocatinlimab significantly improves clinical responses in patients with moderate-to-severe atopic dermatitis by week 2 in a randomized double-blind placebo-controlled phase 2b study
    Guttman-Yassky, Emma
    Esfandiari, Ehsanollah
    Mano, Hirotaka
    Arai, Takahiro
    Kabashima, Kenji
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [4] The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial
    Mehrbani, Mehrzad
    Choopani, Rasool
    Fekri, Alireza
    Mehrabani, Mitra
    Mosaddegh, Mahmoud
    Mehrabani, Mehrnaz
    JOURNAL OF ETHNOPHARMACOLOGY, 2015, 172 : 325 - 332
  • [5] Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study
    Guttman-Yassky, Emma
    Silverberg, Jonathan I.
    Nemoto, Osamu
    Forman, Seth B.
    Wilke, August
    Prescilla, Randy
    de la Pena, Amparo
    Nunes, Fabio P.
    Janes, Jonathan
    Gamalo, Margaret
    Donley, David
    Paik, Jim
    DeLozier, Amy M.
    Nickoloff, Brian J.
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (04) : 913 - +
  • [6] Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: A post hoc integrated analysis of 3 phase 3 randomized, double-blind, placebo-controlled trials
    Mendes-Bastos, Pedro
    Ladizinski, Barry
    Guttman-Yassky, Emma
    Jiang, Ping
    Liu, John
    Prajapati, Vimal H.
    Simpson, Eric L.
    Vigna, Namita
    Teixeira, Henrique D.
    Barbarot, Sebastien
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (04) : 784 - 791
  • [7] Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study
    Gooderham, Melinda
    Guttman-Yassky, Emma
    Igawa, Ken
    Kabashima, Kenji
    Esfandiari, Ehsanollah
    Rylands, Angela J.
    Williams, Angela
    Nixon, Annabel
    Dent, Jennifer E.
    Simpson, Eric
    DERMATOLOGY AND THERAPY, 2024, 14 (12) : 3351 - 3366
  • [8] Fecal microbiota transplantation against moderate-to-severe atopic dermatitis: A randomized, double-blind controlled explorer trial
    Liu, Xiaochun
    Luo, Yang
    Chen, Xingyu
    Wu, Mingyang
    Xu, Xiaoqiang
    Tian, Jingru
    Gao, Yingxia
    Zhu, Jun
    Wang, Zhifeng
    Zhou, Yuan
    Zhang, Yu
    Wang, Xiaokai
    Li, Wei
    Lu, Qianjin
    Yao, Xu
    ALLERGY, 2024,
  • [9] Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial
    Berth-Jones, J
    Takwale, A
    Tan, E
    Barclay, G
    Agarwal, S
    Ahmed, I
    Hotchkiss, K
    Graham-Brown, RAC
    BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (02) : 324 - 330
  • [10] Randomized, double-blind, placebo-controlled trial of autologous blood therapy for atopic dermatitis
    Pittler, MH
    Armstrong, NC
    Cox, A
    Collier, PM
    Hart, A
    Ernst, E
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (02) : 307 - 313
12345